The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dovonex Psoriasis 50 microgram/g ointment



Leo Laboratories LimitedPA0046/064/001

Main Information

Trade NameDovonex Psoriasis 50 microgram/g ointment
Active SubstancesCalcipotriol, anhydrous
Dosage FormOintment
Licence HolderLeo Laboratories Limited
Licence NumberPA0046/064/001

Group Information

ATC CodeD05AX Other antipsoriatics for topical use
D05AX02 calcipotriol

Status

License statusWithdrawn
Withdrawn Date31/05/2021
Legal statusProduct not subject to medical prescription
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportPDF Version
« Back